Download PDF
TumorDiagnostik & Therapie 2017; 38(02): 125-132
DOI: 10.1055/s-0043-100396
Thieme Onkologie aktuell
© Georg Thieme Verlag KG Stuttgart · New York

Die operative Therapie des Endometriumkarzinoms

Bernhard Krämer
,
Florin-Andrei Taran
,
Sara Y. Brucker
Further Information

Publication History

Publication Date:
06 March 2017 (online)

Also available at
    Permissions and Reprints

Epidemiologie

Das Endometriumkarzinom ist der häufigste maligne gynäkologische Tumor der Frau und steht nach dem Mamma-, Lungen- und dem kolorektalen Karzinom insgesamt an 4. Stelle. Typischerweise erkranken postmenopausale Frauen, aber in ca. 20 % der Fälle muss auch prämenopausal mit einer malignen Neoplasie gerechnet werden. Das mittlere Erkrankungsalter liegt aktuell bei etwa 69 Jahren, die Inzidenz steigt mit zunehmendem Lebensalter an. Die altersstandardisierte Mortalität hat in den letzten 30 Jahren abgenommen und geht weiterhin zurück, im internationalen Vergleich zeigt sich in Deutschland eine relativ niedrige Mortalität, was aber nicht darüber hinwegtäuschen darf, dass die krankheitsspezifische 5-Jahres-Mortalität noch bei 19 % liegt.

 

  • Literatur

  • 1 Setiawan VW. Yang HP. Pike MC. et al. Type I and II endometrial cancers: have they different risk factors?. J Clin Oncol 2013; 31: 2607-2618
    CrossrefPubMedGoogle Scholar
  • 2 Brinton LA. Felix AS. McMeekin DS. et al. Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol 2013; 129: 277-284
    CrossrefPubMedGoogle Scholar
  • 3 Levine DA. Lin O. Barakat RR. et al. Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol 2001; 80: 395-398
    CrossrefPubMedGoogle Scholar
  • 4 Segev Y. Iqbal J. Lubinski J. et al. The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. Gynecol Oncol 2013; 130: 127-131
    CrossrefPubMedGoogle Scholar
  • 5 Berek J. Adashi E. Hillard P. Novakʼs Gynecology. 12th ed. Baltimore: Lippincott, Williams & Wilkins; 1996
    Google Scholar
  • 6 Lahti E. Blanco G. Kauppila A. et al. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993; 81: 660-664
    PubMedGoogle Scholar
  • 7 Palomba S. Falbo A. Mocciaro R. et al. Laparoscopic treatment for endometrial cancer: a meta-analysis of randomized controlled trials (RCTs). Gynecol Oncol 2009; 112: 415-421
    CrossrefPubMedGoogle Scholar
  • 8 Berretta R. Merisio C. Melpignano M. et al. Vaginal versus abdominal hysterectomy in endometrial cancer: a retrospective study in a selective population. Int J Gynecol Cancer 2008; 18: 797-802
    CrossrefPubMedGoogle Scholar
  • 9 Susini T. Massi G. Amunni G. et al. Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly. Gynecol Oncol 2005; 96: 362-367
    CrossrefPubMedGoogle Scholar
  • 10 Mariani A. Dowdy SC. Cliby WA. et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008; 109: 11-18
    CrossrefPubMedGoogle Scholar
  • 11 Abu-Rustum NR. Gomez JD. Alektiar KM. et al. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol 2009; 115: 236-238
    CrossrefPubMedGoogle Scholar
  • 12 Todo Y. Yamamoto R. Minobe S. et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol 2010; 119: 60-64
    CrossrefPubMedGoogle Scholar
  • 13 Abu-Rustum NR. Alektiar K. Iasonos A. et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 2006; 103: 714-718
    CrossrefPubMedGoogle Scholar
  • 14 Burke WM. Orr J. Leitao M. et al. SGO Clinical Practice Endometrial Cancer Working Group. Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol 2014; 134: 385-392
    CrossrefPubMedGoogle Scholar
  • 15 Arbeitsgemeinschaft Gynäkologische Onkologie. Empfehlungen für die Diagnostik und Therapie des Endometriumkarzinoms. Aktualisierte Empfehlungen der Kommission Uterus auf Grundlage der S2 k Leitlinie (Version 1.0, 1.6.2008) ohne Angabe der Evidenzlevel und Empfehlungsgrade. Herausgegeben von der Kommission Uterus der Arbeitsgemeinschaft Gynäkologische Onkologie e. V., April 2013.. Im Internet: http://www.ago-online.de/fileadmin/downloads/leitlinien/uterus/empfehlungen_diagnostik_therapie_EC.pdf Stand: 29.01.2016
    PubMedGoogle Scholar
  • 16 Watanabe M. Aoki Y. Kase H. et al. Low risk endometrial cancer: a study of pelvic lymph node metastasis. Int J Gynecol Cancer 2003; 13: 38-41
    CrossrefPubMedGoogle Scholar
  • 17 Burke TW. Levenback C. Tornos C. et al. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996; 62: 169-173
    CrossrefPubMedGoogle Scholar
  • 18 Todo Y. Kato H. Kaneuchi M. et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010; 375: 1165-1172
    CrossrefPubMedGoogle Scholar
  • 19 ASTEC study group. Kitchener H. Swart AM. Qian Q. et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009; 373: 125-136
    CrossrefPubMedGoogle Scholar
  • 20 Abu-Rustum NR. The increasing credibility of sentinel lymph node mapping in endometrial cancer. Ann Surg Oncol 2013; 20: 353-354
    CrossrefPubMedGoogle Scholar
  • 21 Ballester M. Naoura I. Chéreau E. et al. Sentinel node biopsy upstages patients with presumed low- and intermediate-risk endometrial cancer: results of a multicenter study. Ann Surg Oncol 2013; 20: 407-412
    CrossrefPubMedGoogle Scholar
  • 22 Brucker S. Taran FA. Wallwiener D. et al. Sentinel lymph node mapping in endometrial cancer: a concept ready for clinical routine?. Arch Gynecol Obstet 2014; 290: 9-11
    CrossrefPubMedGoogle Scholar
  • 23 Kim CH. Soslow RA. Park KJ. et al. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer 2013; 23: 964-970
    CrossrefPubMedGoogle Scholar
  • 24 Kim CH. Khoury-Collado F. Barber EL. et al. Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion. Gynecol Oncol 2013; 131: 714-719
    CrossrefPubMedGoogle Scholar
  • 25 Kang S. Yoo HJ. Hwang JH. et al. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol 2011; 123: 522-527
    CrossrefPubMedGoogle Scholar
  • 26 Ballester M. Dubernard G. Lécuru F. et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 2011; 12: 469-476
    CrossrefPubMedGoogle Scholar
  • 27 Ozdal B. Unlu BS. Yalcin HR. et al. Role of omentectomy and appendectomy in surgical staging of endometrioid endometrial cancer. Eur J Gynaecol Oncol 2013; 34: 322-324
    PubMedGoogle Scholar
  • 28 Sakai K. Yamagami W. Susumu N. et al. Pathological factors associated with omental metastases in endometrial cancer. Eur J Gynaecol Oncol 2015; 36: 397-401
    PubMedGoogle Scholar
  • 29 Takano M. Ochi H. Takei Y. et al. Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?. Br J Cancer 2013; 109: 1760-1765
    CrossrefPubMedGoogle Scholar
  • 30 Wallwiener D. Jonat W. Kreienberg R. Hrsg. Atlas der gynäkologischen Operationen. 7. Aufl. Stuttgart: Thieme; 2008
    Google Scholar
  • 31 Fehm T. Taran FA. Becker S. Die operative Therapie des Endometriumkarzinoms. Frauenheilkunde up2date 2010; 4: 223-233
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Rutgers JK. Update on pathology, staging and molecular pathology of endometrial (uterine corpus) adenocarcinoma. Future Oncol 2015; 11: 3207-3218
    CrossrefPubMedGoogle Scholar